Literature DB >> 16447130

Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention.

Lance E Rodewald1, Walter A Orenstein, Dean D Mason, Stephen L Cochi.   

Abstract

Although immunization is one of the great public health achievements, continued success depends on an available supply of the vaccines that are recommended for routine use. Beginning in 2000, the United States experienced vaccine supply disruptions of unprecedented scope and magnitude. Although most of the supply disruptions have been resolved, it appears that a fragile vaccine supply will be part of the immunization environment in the United States for the foreseeable future. Here, we describe the perspective of the Centers for Disease Control and Prevention on the recent supply disruptions and the methods used to manage vaccine shortages. The present article focuses on routine pediatric vaccines, including influenza virus vaccine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16447130     DOI: 10.1086/499587

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

1.  Lessons Learned From Making and Implementing Vaccine Recommendations in the U.S.

Authors:  L Reed Walton; Walter A Orenstein; Larry K Pickering
Journal:  Am J Prev Med       Date:  2015-08-18       Impact factor: 5.043

2.  An analysis of the pediatric vaccine supply shortage problem.

Authors:  Sheldon H Jacobson; Edward C Sewell; Ruben A Proano
Journal:  Health Care Manag Sci       Date:  2006-11

3.  Effects of an ongoing epidemic on the annual influenza vaccination rate and vaccination timing among the Medicare elderly: 2000-2005.

Authors:  Byung-Kwang Yoo; Megumi Kasajima; Kevin Fiscella; Nancy M Bennett; Charles E Phelps; Peter G Szilagyi
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

4.  Factors associated with the pricing of childhood vaccines in the U.S. public sector.

Authors:  Weiwei Chen; Mark Messonnier; Fangjun Zhou
Journal:  Health Econ       Date:  2017-06-29       Impact factor: 3.046

Review 5.  How to improve influenza vaccination rates in the U.S.

Authors:  Byung Kwang Yoo
Journal:  J Prev Med Public Health       Date:  2011-07

Review 6.  Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution.

Authors:  Emma Rey-Jurado; Felipe Tapia; Natalia Muñoz-Durango; Margarita K Lay; Leandro J Carreño; Claudia A Riedel; Susan M Bueno; Yvonne Genzel; Alexis M Kalergis
Journal:  Front Immunol       Date:  2018-01-18       Impact factor: 7.561

7.  Current situation, causes, and countermeasures to NIP vaccine shortages in Guangzhou, China.

Authors:  Zhiqun Li; Jindong Xu; Jianxiong Xu; Huifeng Tan; Chunhuan Zhang
Journal:  Hum Vaccin Immunother       Date:  2019-08-12       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.